BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 25178966)

  • 1. Unusual bullous pemphigoid without infiltration of inflammatory cells in the skin lesions.
    Hara H; Makino T; Matsui K; Takegami Y; Koga H; Fukuda S; Ishii N; Hashimoto T; Shimizu T
    Eur J Dermatol; 2014; 24(4):488-9. PubMed ID: 25178966
    [No Abstract]   [Full Text] [Related]  

  • 2. Case of pemphigoid vegetans positive with both BP180 and BP230 in enzyme-linked immunosorbent assays.
    Nagamoto E; Fujisawa A; Jinnin M; Koga H; Ishii N; Hashimoto T; Yoshino Y
    J Dermatol; 2014 Jul; 41(7):667-8. PubMed ID: 24985550
    [No Abstract]   [Full Text] [Related]  

  • 3. Concurrence of autoantibodies to bullous pemphigoid antigens and desmoglein 3: analysis of pathogenic and nonpathogenic antibodies.
    Ono S; Tanioka M; Tanizaki H; Fujisawa A; Koga H; Hashimoto T; Kamiya K; Aoyama Y; Iwatsuki K; Miyachi Y
    Br J Dermatol; 2013 Jun; 168(6):1357-60. PubMed ID: 23738642
    [No Abstract]   [Full Text] [Related]  

  • 4. [Bullous pemphigoid: diagnosis and therapy].
    Kneisel A; Hertl M
    Wien Med Wochenschr; 2014 Sep; 164(17-18):363-71. PubMed ID: 25077677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bullous pemphigoid-like eruption subsequent to scabies: bullous scabies or bullous pemphigoid?
    Huang MX; Li ZS; Luo DQ; Lin Q
    G Ital Dermatol Venereol; 2015 Jun; 150(3):337-9. PubMed ID: 25658439
    [No Abstract]   [Full Text] [Related]  

  • 6. IgG autoantibody reactivity against bullous pemphigoid (BP) 180 and BP230 in elderly patients with pruritic dermatoses.
    Feliciani C; Caldarola G; Kneisel A; Podstawa E; Pfütze M; Pfützner W; Hertl M
    Br J Dermatol; 2009 Aug; 161(2):306-12. PubMed ID: 19485996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum levels of IgE anti-BP180 and anti-BP230 autoantibodies in patients with bullous pemphigoid.
    Ishiura N; Fujimoto M; Watanabe R; Nakashima H; Kuwano Y; Yazawa N; Echigo T; Okochi H; Tamaki K
    J Dermatol Sci; 2008 Feb; 49(2):153-61. PubMed ID: 17920818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An immunogenetic study of bullous pemphigoid with mucosal involvement in two siblings.
    Minagawa A; Arakura F; Koga H; Tokuda Y; Koga H; Hashimoto T; Okuyama R
    Eur J Dermatol; 2015 Apr; 25(2):186-8. PubMed ID: 25513716
    [No Abstract]   [Full Text] [Related]  

  • 9. Immune complex and complement-mediated leukocyte recruitment in bullous pemphigoid.
    Gammon WR
    Immunol Ser; 1989; 46():509-25. PubMed ID: 2488868
    [No Abstract]   [Full Text] [Related]  

  • 10. Vesicular pemphigoid with circulating autoantibodies against 230-kDa and 180-kDa proteins, and additional autoantibodies against 97-kDa and 45-kDa proteins.
    Lai FJ; Sheu HM; Lee JY; Cheng CL; Chen W
    Int J Dermatol; 2007 Feb; 46(2):206-9. PubMed ID: 17269979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pemphigoid gestationis with autoantibodies exclusively directed to the 230-kDa bullous pemphigoid antigen (BP230Ag).
    Ghohestani R; Nicolas JF; Kanitakis J; Bedane C; Faure M; Claudy A
    Br J Dermatol; 1996 Mar; 134(3):603-4. PubMed ID: 8731696
    [No Abstract]   [Full Text] [Related]  

  • 12. [Auto-immune bullous diseases autoantibodies (pemphigus, bullous pemphigoid): what the dermatologist must know].
    Ingen-Housz-Oro S; Hüe S; Grootenboer-Mignot S; André C
    Ann Dermatol Venereol; 2013; 140(8-9):563-70. PubMed ID: 24034645
    [No Abstract]   [Full Text] [Related]  

  • 13. ELISA instead of indirect IF in patients with BP: Comment on "Usefulness of BP230 and BP180-NC16a enzyme-linked immunosorbent assays in the initial diagnosis of bullous pemphigoid".
    Chan LS
    Arch Dermatol; 2011 Mar; 147(3):291-2. PubMed ID: 21422335
    [No Abstract]   [Full Text] [Related]  

  • 14. Enzyme-linked immunosorbent assay for the combination of bullous pemphigoid antigens 1 and 2 in the diagnosis of bullous pemphigoid.
    Roussel A; Benichou J; Randriamanantany ZA; Gilbert D; Drenovska K; Houivet E; Tron F; Joly P
    Arch Dermatol; 2011 Mar; 147(3):293-8. PubMed ID: 21422336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bullous pemphigoid of childhood: immunofluorescent investigation.
    Tamaki K; Igarashi A; Nakamura K; Nashiro K; Okochi H; Seki Y; Tsuchida T
    J Dermatol; 1988 Oct; 15(5):400-4. PubMed ID: 3065382
    [No Abstract]   [Full Text] [Related]  

  • 16. The immunopathology of bullous pemphigoid.
    Imber MJ; Murphy GF; Jordon RE
    Clin Dermatol; 1987; 5(1):81-92. PubMed ID: 3552196
    [No Abstract]   [Full Text] [Related]  

  • 17. Autoantibodies from patients with localized and generalized bullous pemphigoid immunoprecipitate the same 230-kd keratinocyte antigen.
    Domloge-Hultsch N; Utecht L; James W; Yancey KB
    Arch Dermatol; 1990 Oct; 126(10):1337-41. PubMed ID: 2221940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of bullous pemphigoid antibodies in dermal-epidermal separation.
    Haustein UF
    J Invest Dermatol; 1989 Jan; 92(1):133. PubMed ID: 2642509
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical and immunological factors associated with bullous pemphigoid relapse.
    Fine JD
    JAMA Dermatol; 2014 Jan; 150(1):34. PubMed ID: 24226151
    [No Abstract]   [Full Text] [Related]  

  • 20. IgE autoantibodies in bullous pemphigoid: supporting role, or leading player?
    Ujiie H
    J Dermatol Sci; 2015 Apr; 78(1):5-10. PubMed ID: 25797172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.